# NIH Reporter #1F31HL184854-01

Optimization of enhanced in situ protein production for FVIII replacement using modular, rationally designed translatable ribonucleic acids expressing self-replicative machinery

**Recipient:** Boston University (Charles River Campus)

**Award Amount:** $43,321.00
**Ceiling:** $43,321.00

**Awarded:** August 06, 2026

**Identifier:** 1F31HL184854-01

A National Heart, Lung, and Blood Institute fellowship supports Wyatt Becicka’s research and training at Boston University to develop self-amplifying RNA approaches for improved factor VIII replacement therapy.

### Description

Fellowship research to develop self-amplifying RNAs for factor VIII protein replacement therapy, including optimizing RNA delivery, replication, safety, efficacy, and immune response.

[View original record](https://reporter.nih.gov/search/a_XEnEpPR0i-06zXlbqcPw/project-details/11317990)
